Business


Looking Back: Trump's First 100 Days

Most of those who approve of Trump's handling of his job as president say he is doing about as they expected (56%) or better (41%). The president has already sent a "strong message about where his sympathies lie" despite what happens with the plan, the editorial said.



China cautions against use of force on North Korea

Opinion: Who's the chicken in Trump's high-stakes game? In an exclusive interview to Reuters , President Trump said North Korea under the dictatorship of Kim Jong-un was his biggest global challenge. "I can say in terms of solving the North Korean crisis, China's efforts can't be overstated". "The core to me is that this will not be solved unless the USA and China can overcome enough of their mutual mistrust to figure out a long-term future for Korea".



Comprehensive Stock Analysis Of Zynga, Inc. (ZNGA)

Over the 52-week time span, the stock notched a high price of $3.08 and its minimum price was $2.27. Canaccord Genuity reissued a hold rating and set a $3.00 target price on shares of Zynga in a report on Tuesday, January 3rd. If you are reading this report on another publication, it was stolen and republished in violation of US & worldwide copyright and trademark legislation.


Nasdaq hits 6000 as strong profits push stocks higher

Nasdaq hits 6000 as strong profits push stocks higher

Companies in the S&P 500 are on track to report overall growth of about 10 percent in first-quarter earnings per share, according to S&P Global Market Intelligence. It also raised its forecast for full-year results. But it has been the technology-laden index of 100 Nasdaq stocks that has delivered the far superior performance, rising 11 percent year to date - about twice the gains of the Dow and S&P 500 .


ResMed Inc. (RMD) Given Sell Rating at Jefferies Group LLC

ResMed Inc. (RMD) Given Sell Rating at Jefferies Group LLC

On average, equities research analysts anticipate that ResMed will post $2.82 EPS for the current fiscal year. TRADEMARK VIOLATION NOTICE: " ResMed Inc ". Following the sale, the chief financial officer now directly owns 65,283 shares in the company, valued at $4,731,711.84. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website .